Differential prognostic significance of platelet reactivity based on ischemic risk after percutaneous coronary intervention

Back

ESC Premium Access

Differential prognostic significance of platelet reactivity based on ischemic risk after percutaneous coronary intervention

Session: Bleeding and antiplatelet strategies in acute coronary syndromes

Topic: Pharmacotherapy

Speaker: Assistant Professor K. Jeon (Seongnam, KR)

Event: ESC Congress 2024

Congress Presentation

About the speaker

Assistant Professor Ki-Hyun Jeon

Seoul National University Bundang Hospital, Seongnam (Korea (Republic of))

0 follower

7 more presentations in this session

Temporal trends in major bleeding after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction from 2003 to 2017: the Western Denmark Heart Registry

Speaker: Doctor P. Thrane (Aarhus, DK)

Thirty days clinical outcomes following stent implantation with aspirin-free prasugrel monotherapy in non-ST segment elevation myocardial infarction. Interim report from ASET-Japan pilot study

Speaker: Doctor K. Miyashita (Galway, IE)

Ticagrelor vs. clopidogrel in ST elevation myocardial infarction patients with hemoglobin > 160

Speaker: Doctor T. Gu (Tianjin, CN)

Safety and effectiveness of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: insights from the SPUM-ACS study

Speaker: Doctor F. Bruno (Turin, IT) Doctor F. Wenzl (Zurich, CH)

Association of P2Y12 inhibitor pretreatment strategy with short and long term ischemic and bleeding outcomes in NSTE-ACS patients

Speaker: Doctor K. Keskin (Istanbul, TR) Associate Professor A. Calik (Istanbul, TR)

Access the full session

Bleeding and antiplatelet strategies in acute coronary syndromes

Speakers: Assistant Professor K. Jeon, Doctor P. Thrane, Doctor K. Miyashita, Doctor T. Gu, Doctor F. Bruno...

Access

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources